Patent US5447841A successfully refreshed from Google Patents.
← Back to Patent Explorer
US5447841A Expired / Lapsed US ⏱️ 0.0 years remaining

Methods for chromosome-specific staining

Assignee: University of California Berkeley
•
Filing: 1990-12-14
•
Granted: 1995-09-05
•
Expires: 2010-12-14
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Methods and compositions for chromosome-specific staining are provided. Compositions comprise heterogenous mixtures of labeled nucleic acid fragments having substantially complementary base sequences to unique sequence regions of the chromosomal DNA for which their associated staining reagent is specific. Methods include methods for making the chromosome-specific staining compositions of the invention, and methods for applying the staining compositions to chromosomes.

Inventors

  • 👤 Joe W. Gray
  • 👤 Daniel Pinkel

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-06 17:13
CPC Classifications
C; C12; C12Q; C12Q1/00; C12Q1/68; C12Q1/6813; C12Q1/6832; C12Q1/6811; C12Q1/6841; C12Q1/6844; C12Q1/6853; C12Q1/6876; C12Q1/6879; C12Q1/6883; C12Q1/6886; C12Q2600/00; C12Q2600/156; Y; Y10; Y10S; Y10S435/00; Y10S435/805; Y10S435/82

Claims Analysis

Total Claims: 18
Claim 1
Independent Claim 141 words
A method of staining target chromosomal DNA comprising: (a) providing 1) labeled nucleic acid that comprises fragments which are substantially complementary to nucleic acid segments within the chromosomal DNA for which detection is desired, and 2) blocking nucleic acid that comprises fragments which are substantially complementary to repetitive segments in the labeled nucleic acid; and (b) employing said labeled nucleic acid, blocking nucleic acid, and chromosomal DNA in in situ hybridization so that labeled repetitive segments are substantially blocked from binding to the chromosomal DNA, while hybridization of unique segments within the labeled nucleic acid to the chromosomal DNA is allowed, wherein blocking of the labeled repetitive segments is sufficient to permit detection of hybridized labeled nucleic acid containing unique segments, and wherein the chromosomal DNA is present in a morphologically identifiable chromosome or cell nucleus during the in situ hybridization.
Claim 2
Independent Claim 141 words
A method of staining target chromosomal DNA comprising: (a) providing 1) labeled nucleic acid that comprises fragments which are substantially complementary to nucleic acid segments within the chromosomal DNA for which detection is desired, and 2) blocking nucleic acid that comprises fragments which are substantially complementary to repetitive segments in the labeled nucleic acid; and (b) employing said labeled nucleic acid, blocking nucleic acid, and chromosomal DNA in in situ hybridization so that labeled repetitive segments are substantially blocked from binding to the chromosomal DNA, while hybridization of unique segments within the labeled nucleic acid to the chromosomal DNA is allowed, wherein blocking of the labeled repetitive segments is sufficient to permit detection of hybridized labeled nucleic acid containing unique segments, and wherein the chromosomal DNA is present in a morphologically identifiable chromosome or cell nucleus during the in situ hybridization.
Claim 3
Dependent Claim 29 words
The method of claim 1 wherein the blocking nucleic acid is hybridized with the labeled nucleic acid prior to hybridization of the labeled nucleic acid with the chromosomal DNA.
Claim 4
Dependent Claim 28 words
The method of claim 1 wherein the blocking nucleic acid is hybridized with the chromosomal DNA prior to hybridization of the labeled nucleic acid with the chromosomal DNA.
Claim 5
Dependent Claim 35 words
The method of claim 1 wherein the blocking nucleic acid is hybridized with the labeled nucleic acid and separately with the chromosomal DNA prior to hybridization of the labeled nucleic acid with the chromosomal DNA.
Claim 6
Dependent Claim 26 words
The method of claim 1 wherein the labeled nucleic acid, the blocking nucleic acid, and the chromosomal DNA are hybridized together during in situ hybridization step.
Claim 7
Dependent Claim 33 words
The method of claim 1 wherein the labeled nucleic acid comprises fragments which are designed to allow detection of extra or missing chromosomes, extra or missing portions of a chromosome, or chromosomal rearrangements.
Claim 8
Dependent Claim 15 words
The method of claim 6 wherein the chromosomal rearrangement is a translocation or an inversion.
Claim 9
Dependent Claim 24 words
The method of claim 6 wherein the labeled nucleic acid is designed to allow detection of a chromosomal rearrangement consistent with chronic myelogenous leukemia.
Claim 10
Dependent Claim 17 words
The method of claim 6 wherein the labeled nucleic acid is designed to allow detection of aneuploidy.
Claim 11
Dependent Claim 12 words
The method of claim 6 wherein the extra chromosome is chromosome 21.
Claim 12
Dependent Claim 43 words
The method of claim 1 wherein the labeled nucleic acid comprises fragments complementary to the total genomic complement of chromosomes, fragments complementary to a single chromosome, fragments complementary to a subset of chromosomes, or fragments complementary to a subregion of a single chromosome.
Claim 13
Dependent Claim 24 words
The method of claim 11 wherein the fragments are selected from the nucleic acid of normal human chromosomes 1 through 22, X, and Y.
Claim 14
Dependent Claim 15 words
The method of claim 1 wherein the chromosomal DNA is metaphase or interphase chromosomal DNA.
Claim 15
Dependent Claim 22 words
The method of claim 1 wherein the repetitive segments comprise segments which are substantially complementary to highly repetitive segments and middle-repetitive segments.
Claim 16
Dependent Claim 16 words
The method of claim 14 wherein the repetitive segments are substantially complementary to satellite repetitive segments.
Claim 17
Dependent Claim 25 words
The method of claim 14 wherein the repetitive segments are substantially complementary to tandem repetitive segments or repetitive segments located in regions of centromeric heterochromatin.
Claim 18
Dependent Claim 16 words
The method of claim 14 wherein the repetitive segments are substantially complementary to interspersed repetitive segments.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1998-09-04 1999-03-06 1999-09-05 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2002-09-04 2003-03-06 2003-09-05 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2006-09-04 2007-03-06 2007-09-05 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag